Finall Exam:l NU665B/l NUl 665Bl (Latestl
2025/l 2026l Update)l Primaryl Carel ofl Familyl II Guide|l Questionsl &l Answers|l Gradel A|l 100%l Correctl (Verifiedl Solutions)-l Regis
Q:l TBl incidence
Answer:
1/3l ofl thel popylationl hasl latentl TD
weaklyl graml +l bacillus
acidl fastl duel tol lipidl richl celll wall-l mycobacterial stainl red
obligatel aerobe-l takesl upl tol 60l daysl tol grow
Q:l TBl symptoms
Answer:
-chronicl coughl >l 2-3l weeks -fever -nightl sweats -lossl ofl appetite -weightl loss -fatigue -symptomsl attributablel tol localizedl disease
Q:l variablel presentationsl ofl TB
Answer:
-mostl healthl adultsl developl pulmonaryl TB -upl tol 25%l ofl childrenl withl activel diseasel havel extrapulmonaryl diseasel (egl disseminatedl TBl orl TBl meningitis) 1 / 4
pleural.l pericardial,l GI,l lymphl nodes,l GU,l skeletall (gibbusl formation/l pott'sl disease)
Q:l TBl diagnosticl options
Answer:
symptoml based -chronicl coughl >4l weeks,l weightl loss,l fever,l nightl sweats
clinicall examl findingsl suggestivel ofl dx -gibbusl orl onl painful,l fistulizingl cervicall LAN
CXR -negativel inl upl tol 50%l ofl kidsl withl activel TBl
-skinl test
-quaniferon
-tissuel pathology
Q:l txl forl TB
Answer:
initiation -rifampinl orl rifabutin -isoniazid -pyrazinamide -ethambutol x2l monthsl (RIPE)
continuation -rif -INH x4l months
Q:l whenl tol treatl hisl andl TBl coinfection
Answer: 2 / 4
startl TBl txl firstl thenl startl ARTl withinl 2-8l weeks -forl CD4l <50l cells/micoL,l startl ARTl withinl 2l weeksl afterl ATT -forl CD4l >50,l startl ARTl withinl 8l weeksl afterl ATT -ifl CNSl invovlemtn,l delayl ARTl forl aboutl 8l weeksl regardlessl ofl CD4
-ARTl oftenl requiresl dosel adjustmentsl duel tol rifampin
Q:l TBl testingl forl HCP
Answer:
baselinel testingl recommendedl butl nol seriall testingl unlessl therel hasl beenl exposure
Q:l testingl forl TB
Answer:
IGRA -usedl inl peoplel withl poorl ratesl ofl returnl forl TSTl readingl andl interpretation -peoplel whol havel recievedl BCGl vaccine
TST -preferredl inl kidsl 5l andl younger
Q:l whatl constitutesl al positivel PPD/TST?
Answer:
>5mm:l HIV+,l closel activel case,l CXRl lesions,l personsl onl steriods,l transplanl patients
>10mm:l highl prevalencel country,l IDUl andl HIVl neg,l medicallyl underseed,l longl terml care
>15mm:l nol increasedl risk
historyl ofl BCGl shouldl notl affectl interpretationl ofl resultsl becausel BCGl cross-reactivityl wanesl withl time
Q:l txl forl LTBI
- / 4
Answer:
isoniazidl andl rifantine:l 3l monthsl weekly***
-(DOl NOTl USEl inl kidsl underl 2l orl pregnantl women)
rifampin:l 4l months
isoniazidl andl rifampin:l 3l monthsl
INHl forl 9l monthsl ifl preg*
Q:l howl muchl radl isl okayl inl preg
Answer:
5l rad
Q:l tendon
Answer:
connectl musclesl tol bones,l enablingl movementl byl transmittingl forcel froml musclesl tol bones,
Q:l ligament
Answer:
al fibrousl connectivel tissuel whichl attachesl bonel tol bone,l andl usuallyl servesl tol holdl structuresl togetherl andl keepl theml stable
Q:l adhesivel capsulitis
Answer:
-frozenl shoulder -lossl ofl activel andl passivel motion -xl rayl tol r/ol fracture,l osteophtes,l loosel bodies,l tremors
-MRI:l tol viewl capsule,l rulel outl rotatorl cuffl tear
-tx:l nonl surgical:l NSAID,l moistl heat,l injectionsl PT -surgeyry:l stretchl orl releasel thel contractedl jointl capsulel withl manipulstionl orl arthroscopy
- / 4